Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2022 / 08:45PM GMT
Release Date Price: €128 (-1.54%)
Unidentified Analyst

Good afternoon, everyone, and thank you for joining us on the third day of JPMorgan Healthcare Conference. My name is [Eugene Naam] and I'm an associate with the JPMorgan healthcare team. A quick housekeeping item before we proceed to the presentation. (Operator Instructions)

With that, I am pleased and excited to introduce you to today's speakers from Amedisys. With us today, we have CEO, Paul Kusserow; President and COO, Chris Gerard; and finally, CFO, Scott Ginn.

Without further ado, I'll turn it over to you, team.

Paul Berthold Kusserow
Amedisys, Inc. - Chairman & CEO

Thanks, [Eugene] appreciate it. Hi, this is Paul. We're excited to be able to present and we'll miss the fun times at the St. Francis Hotel, but we're here calling from Nashville. We wanted -- there were some news earlier this week that several people have asked about in our breakout meetings. It's the succession. I'll retiring as CEO on April 15, moving on to the Chairman role and happily, Chris Gerard, who's right across the table from me, will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot